287 related articles for article (PubMed ID: 34602476)
1. Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia.
Stanitsa E; Economou A; Beratis I; Kontaxopoulou D; Fragkiadaki S; Papastefanopoulou V; Pavlou D; Papantoniou P; Kroupis C; Papatriantafyllou J; Stefanis L; Yannis G; Papageorgiou SG
J Alzheimers Dis; 2021; 84(3):1005-1014. PubMed ID: 34602476
[TBL] [Abstract][Full Text] [Related]
2. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
[TBL] [Abstract][Full Text] [Related]
3. Peripheral Blood Biomarkers Coupled with the Apolipoprotein E4 Genotype Are Strongly Associated with Semantic and Episodic Memory Impairments in Elderly Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease.
Supasitthumrong T; Tunvirachaisakul C; Aniwattanapong D; Tangwongchai S; Chuchuen P; Tawankanjanachot I; Snabboon T; Hemrungrojn S; Carvalho AF; Maes M
J Alzheimers Dis; 2019; 71(3):797-811. PubMed ID: 31424390
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E4 Allele and Gait Performance in Mild Cognitive Impairment: Results From the Gait and Brain Study.
Sakurai R; Montero-Odasso M
J Gerontol A Biol Sci Med Sci; 2017 Nov; 72(12):1676-1682. PubMed ID: 28482102
[TBL] [Abstract][Full Text] [Related]
5. Motor timing intraindividual variability in amnestic mild cognitive impairment and cognitively intact elders at genetic risk for Alzheimer's disease.
Kay CD; Seidenberg M; Durgerian S; Nielson KA; Smith JC; Woodard JL; Rao SM
J Clin Exp Neuropsychol; 2017 Nov; 39(9):866-875. PubMed ID: 28052734
[TBL] [Abstract][Full Text] [Related]
6. Subjective cognitive decline, APOE e4 allele, and the risk of neurocognitive disorders: Age- and sex-stratified cohort study.
Liew TM
Aust N Z J Psychiatry; 2022 Dec; 56(12):1664-1675. PubMed ID: 35229693
[TBL] [Abstract][Full Text] [Related]
7. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
[TBL] [Abstract][Full Text] [Related]
8. APOE and mild cognitive impairment: the Framingham Heart Study.
Jefferson AL; Beiser AS; Seshadri S; Wolf PA; Au R
Age Ageing; 2015 Mar; 44(2):307-11. PubMed ID: 25497326
[TBL] [Abstract][Full Text] [Related]
9. Sex Difference in the Association of APOE4 with Memory Decline in Mild Cognitive Impairment.
Wang X; Zhou W; Ye T; Lin X; Zhang J;
J Alzheimers Dis; 2019; 69(4):1161-1169. PubMed ID: 31127771
[TBL] [Abstract][Full Text] [Related]
10. Large intracranial volume accelerates conversion to dementia in males and APOE4 non-carriers with mild cognitive impairment.
An H; Son SJ; Cho S; Cho EY; Choi B; Kim SY;
Int Psychogeriatr; 2016 May; 28(5):769-78. PubMed ID: 26674540
[TBL] [Abstract][Full Text] [Related]
11. Severity-Related Increase and Cognitive Correlates of Serum VEGF Levels in Alzheimer's Disease ApoE4 Carriers.
Alvarez XA; Alvarez I; Aleixandre M; Linares C; Muresanu D; Winter S; Moessler H
J Alzheimers Dis; 2018; 63(3):1003-1013. PubMed ID: 29710700
[TBL] [Abstract][Full Text] [Related]
12. Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.
Kennedy RE; Cutter GR; Wang G; Schneider LS
J Alzheimers Dis; 2016; 50(4):1205-15. PubMed ID: 26836180
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of four subtypes of mild cognitive impairment and APOE in a Japanese community.
Sasaki M; Kodama C; Hidaka S; Yamashita F; Kinoshita T; Nemoto K; Ikejima C; Asada T
Int J Geriatr Psychiatry; 2009 Oct; 24(10):1119-26. PubMed ID: 19449451
[TBL] [Abstract][Full Text] [Related]
14. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
Low A; Ng KP; Chander RJ; Wong B; Kandiah N
J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E genotype and physical function among older people with mild cognitive impairment.
Doi T; Shimada H; Makizako H; Tsutsumimoto K; Uemura K; Suzuki T
Geriatr Gerontol Int; 2015 Apr; 15(4):422-7. PubMed ID: 24730603
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
[TBL] [Abstract][Full Text] [Related]
17. Interaction effects of subjective memory impairment and ApoE4 genotype on episodic memory and hippocampal volume.
Striepens N; Scheef L; Wind A; Meiberth D; Popp J; Spottke A; Kölsch H; Wagner M; Jessen F
Psychol Med; 2011 Sep; 41(9):1997-2006. PubMed ID: 21284913
[TBL] [Abstract][Full Text] [Related]
18. Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status.
Reas ET; Triebswetter C; Banks SJ; McEvoy LK
Alzheimers Res Ther; 2024 Jan; 16(1):7. PubMed ID: 38212861
[TBL] [Abstract][Full Text] [Related]
19. A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment.
Hird MA; Egeto P; Fischer CE; Naglie G; Schweizer TA
J Alzheimers Dis; 2016 May; 53(2):713-29. PubMed ID: 27176076
[TBL] [Abstract][Full Text] [Related]
20. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.
Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB
Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
